Top Story

Omeros granted CMS pass-through reimbursement status for Omidria

October 31, 2014

The Center for Medicare and Medicaid Services has granted Omeros Corporation with transitional pass-through status for Omidria 1%/0.3%, according to an Omeros press release.

This status — effective Jan. 1, 2015 — will allow ambulatory surgery centers and other outpatient facilities to bill Medicare and other insurance providers for the phenylephrine and ketorolac injection using a temporary Healthcare Common Procedure Coding System code unique to Omidria, according to the release.

CEDARS DebatePublication Exclusive

Optimization of ocular surface requires newer treatment options

October 31, 2014
The ocular surface and tear film can no longer be ignored, nor should they be. We have long been aware of the problems of chronic dry eye and the damage that can occur…
Worth Building

Question your allocation to deal with recent stock market volatility

October 30, 2014
The summer stock market doldrums have morphed into a high octane volatile zig-zag. So I ask you – what is new? Haven’t we been here before? The trouble is…

Nicox finalizes acquisition of Aciex Therapeutics

October 30, 2014
Nicox has announced the completion of its acquisition of Aciex Therapeutics, according to a press release.In July,
More News Headlines »
Case Report

Intravitreal Polypoidal Choroidal Vasculopathy in Radiation Retinopathy

Ophthalmic Surgery, Lasers and Imaging Retina
Online Advanced Release, October 29, 2014
A 30-year-old woman diagnosed with choroidal melanoma and treated with plaque radiation and transpupillary…
More »

In Focus: Advances in AMD - Clinical Case: Long-term Management of Established Age-related Macular Degeneration

This activity is supported by an educational grant from Genentech, Inc.

Long-term management of wet age-related macular degeneration can be challenging, as medications and dosing schedules…
More »
Meeting News Coverage Video

Light adjustable lens allows precise refractive results

October 30, 2014
CHICAGO – At the American Academy of Ophthalmology, James Lehmann, MD, discusses his clinical study results…
More »